Instead of focusing on new variant-specific vaccines, the emphasis should be on deploying existing vaccines as fast as possible to as many people.
- Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
We are being cautious about the implications for vaccine efficacy and transmissibility while we gather more data to understand this lineage.
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.
Contact Penny for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Johannesburg, South Africa
- Article Feed
- Joined



